Hepatobiliary Disease Platform

The hepatobiliary system (comprised of the liver, gallbladder, and bile ducts) plays an important role in digestion and in the biotransformation and disposition of endogenous molecules and drugs. Hepatobiliary diseases range from minor infection or scarring to serious conditions such as cancer. At this year’s EASL conference, WuXi AppTec showcased our comprehensive platform of hepatobiliary-related services, such as our CAP-certified pathology laboratory and our extensive panel of animal disease models, including NAFLD, fibrosis, cirrhosis, and a clinically relevant NASH mouse model.

Hepatobiliary Disease Platform

  • All-encompassing hepatobiliary disease models:
    • NAFLD, NASH, Fibrosis, Cirrhosis, PBC/PSC, ALD, and more
  • Comprehensive hepatic tissue bank and transcriptomics database
  • Professional quantitative analysis in pathology

Histopathology Laboratory

  • CAP-certified pathology laboratory
  • Tissue processor
  • Embedding center
  • Cyostats
  • Microtomes
  • Staining workstation
  • IHC & ISH stainer
  • Laser-scanning confocal microscope
  • HALO-AI quantitative histopathology


Hepatobiliary_Disease Platform

Download

← Return to Resources

Related Content

Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a serious liver disease. If left untreated, MASH can...

VIEW RESOURCE

Introduction: OncoWuXi Express will continue to keep you informed about updates to our online pharmacology model database (OncoWuXi Database), as...

VIEW RESOURCE
← View all in vivo Pharmacology Resources
× peptide, amino acid

Contact An Expert Today!